These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32329358)

  • 1. Benefits of micronutrient supplementation for reducing the risk of wet age-related macular disease and diabetic retinopathy: An update.
    Battaglia Parodi M; Brunoro A; Tomasso L; Scuderi G
    Eur J Ophthalmol; 2020 Jul; 30(4):780-794. PubMed ID: 32329358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?
    Kowluru RA; Zhong Q
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8665-71. PubMed ID: 22065212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does laser still have a role in the management of retinal vascular and neovascular diseases?
    Shah AM; Bressler NM; Jampol LM
    Am J Ophthalmol; 2011 Sep; 152(3):332-339.e1. PubMed ID: 21742309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.
    Rakoczy EP; Lai CM; Magno AL; Wikstrom ME; French MA; Pierce CM; Schwartz SD; Blumenkranz MS; Chalberg TW; Degli-Esposti MA; Constable IJ
    Lancet; 2015 Dec; 386(10011):2395-403. PubMed ID: 26431823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy.
    Gong X; Rubin LP
    Arch Biochem Biophys; 2015 Apr; 572():40-48. PubMed ID: 25701588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vision Loss in Older Adults.
    Pelletier AL; Rojas-Roldan L; Coffin J
    Am Fam Physician; 2016 Aug; 94(3):219-26. PubMed ID: 27479624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.
    Van Hove I; Hu TT; Beets K; Van Bergen T; Etienne I; Stitt AW; Vermassen E; Feyen JHM
    Prog Retin Eye Res; 2021 Nov; 85():100966. PubMed ID: 33775825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of patients presenting with exudative maculopathy and neovascular retinal disease in an urban population.
    Ergun E; Abramov A; Zawinka C; Stur M
    Wien Klin Wochenschr; 2004 Nov; 116(21-22):737-43. PubMed ID: 15628644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering the risk of visual impairment and blindness.
    Cunha-Vaz J
    Diabet Med; 1998; 15 Suppl 4():S47-50. PubMed ID: 9868992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
    Emerson MV; Lauer AK
    BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Coherence Tomography-Angiography of Different Choroidal Neovascularization Subtypes in Wet Age-related Macular Degeneration.
    Stavrev VN; Sivkova NP; Koleva-Georgieva DN
    Folia Med (Plovdiv); 2019 Jun; 61(2):317-326. PubMed ID: 31301657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy.
    Alfonso-Muñoz EA; Burggraaf-Sánchez de Las Matas R; Mataix Boronat J; Molina Martín JC; Desco C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional supplements in age-related macular degeneration.
    Schmidl D; Garhöfer G; Schmetterer L
    Acta Ophthalmol; 2015 Mar; 93(2):105-21. PubMed ID: 25586104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study.
    Bellmann C; Unnebrink K; Rubin GS; Miller D; Holz FG
    Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):968-74. PubMed ID: 13680248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
    Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
    Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
    Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.